Outsourcing in Clinical Trials (OCT) Europe 2024
OCT Europe will provide delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials.
Stop by the Clario Booth #57 during the conference to talk with our experts and find out what’s new.
Session information:
Title: A holistic approach to Parkinson’s disease endpoint data collection: efficacy, safety and quality of life
Date: Tuesday, May 7, 2024
Time: 12:30 p.m. – 1:00 p.m.
Stream B: Clinical Technology & Innovation
Abstract:
Join us for a comprehensive exploration into Parkinson’s disease (PD) endpoint data collection, as we delve into the core elements of efficacy, safety, and quality of life. This session will highlight how the integration of different endpoint modalities provides researchers with a clear advantage in their mission to advance innovative therapeutics for this largely unmet medical need. The endpoint modalities to be discussed include:
- Wearable digital endpoint solutions and their pivotal role in providing quantitative gait assessment for detection of disease progression
- eCOA solutions for assessing efficacy and quality of life, leveraging clinical rating scales, symptom diaries, and other patient-reported outcome measures
- Medical imaging modalities focused on accurately characterizing PD status biologically, paving the way for biomarker-guided drug development
- Cardiac monitoring in this unique population, collecting high-quality blood pressure and cardiac rhythm data to characterize PD-associated autonomic dysfunction
Speakers
Todd Rudo, M.D.
Chief Medical Officer at Clario
As Clario’s Chief Medical Officer, Dr. Todd Rudo provides medical and scientific leadership across the organization. Passionate about leveraging Clario’s scientific resources to support customer success, Dr. Rudo has focused efforts on developing expertise across a range of therapeutic areas. His team provides expert consulting to clients on scientific and regulatory strategy, and ensures Clario’s product portfolio is scientifically robust, generating high quality clinical trial endpoint data. Dr. Rudo has a particular interest in applying innovative technologies to improve the scientific rigor of clinical trials, while also maintaining focus on patient and site burden. With nearly 20 years of clinical cardiology and pharmaceutical research experience, Dr. Rudo has focused predominantly on drug safety, working across a wide range of therapeutic areas.
Bryan McDowell, M.Sc., MBA
Vice President, eCOA Clinical Science & Consulting at Clario
In his role as VP, eCOA Science & Consulting, Bryan brings extensive experience and expertise to achieve smarter drug development, clinical trial design and execution (including decentralized and remote trials) to vastly expand the reach and access of trials to more patients, provide improved patient experience and data quality to deliver accelerated drug & device development programs. Bryan is a thought leader and recognized strategist & visionary and continues to influence, drive and deliver on the pharma-wide industry necessity for smarter drug & device development and life cycle management
Meet with us at Outsourcing in Clinical Trials (OCT) Europe 2024.
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.